These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24624865)
1. [The resolution of the XXVIII (91th) session of the RAMS General Meeting "Cell Technologies and Regenerative Medicine"]. Dedov II; Tutel'ian VA Vestn Ross Akad Med Nauk; 2013; (9):4-6. PubMed ID: 24624865 [No Abstract] [Full Text] [Related]
2. Recent Progress in Cell Therapy and Regenerative Medicine for Neurological Disorders: Introduction to the ASNTR Special Issue From the 2016 Meeting. Borlongan CV Cell Transplant; 2017 Apr; 26(4):529-530. PubMed ID: 28403912 [No Abstract] [Full Text] [Related]
3. Manufacturing challenges in regenerative medicine. Martin I; Simmons PJ; Williams DF Sci Transl Med; 2014 Apr; 6(232):232fs16. PubMed ID: 24739757 [TBL] [Abstract][Full Text] [Related]
4. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Mason C; Manzotti E Regen Med; 2010 May; 5(3):307-13. PubMed ID: 20455641 [No Abstract] [Full Text] [Related]
5. Regenerative medicine: future impact on clinical therapies and society. Kargul J; Laurent GJ; Irminger-Finger I Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768 [No Abstract] [Full Text] [Related]
7. Organ Chips: Quality Assurance Systems in Regenerative Medicine. Pasqualini FS; Emmert MY; Parker KK; Hoerstrup SP Clin Pharmacol Ther; 2017 Jan; 101(1):31-34. PubMed ID: 27709615 [TBL] [Abstract][Full Text] [Related]
8. Small molecules and small molecule drugs in regenerative medicine. Lu B; Atala A Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867 [TBL] [Abstract][Full Text] [Related]
12. Balancing Safety and Efficacy With Early Availability in the Regulation of Regenerative Medicine Product. Fujiwara Y; Maruyama Y; Honda F Clin Pharmacol Ther; 2021 May; 109(5):1182-1185. PubMed ID: 32979224 [No Abstract] [Full Text] [Related]
13. Progress in cellular neurorestoratology: a brief introduction to the IANR supplement issue. Huang H Cell Transplant; 2013; 22 Suppl 1():S1-3. PubMed ID: 24152970 [No Abstract] [Full Text] [Related]
14. First Approval of Regenerative Medical Products under the PMD Act in Japan. Konishi A; Sakushima K; Isobe S; Sato D Cell Stem Cell; 2016 Apr; 18(4):434-5. PubMed ID: 27058934 [No Abstract] [Full Text] [Related]
15. Transforming the Approach to Cell-Based Therapies. Atala A; McAllister TN Stem Cells Transl Med; 2017 May; 6(5):1305-1306. PubMed ID: 28456006 [No Abstract] [Full Text] [Related]
16. Preparing regenerative therapies for clinical application: proposals for responsible translation. Shapiro SA; Smith CG; Arthurs JR; Master Z Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044 [No Abstract] [Full Text] [Related]
17. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada. Roy DC; Alarco AM; Isasi R Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957 [TBL] [Abstract][Full Text] [Related]